Company Filing History:

8 out of 30

Toa Eiyo Ltd.

patents

3 out of 49

Yamasa Shoyu Kabushiki Kaisha

patents

1 out of 191

Sagami Chemical Research Center

patents

4. 1 out of 1

Sagami Chemical Research Center Toa Eiyo Ltd.

patent

where one patent can have more than one assignee

Years Active: 1989-2001

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6258829 - Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same (2001-07-10),

2. 5728835 - Substituted cyclic amine compound, production process thereof and (1998-03-17),

3. 5459254 - Process for preparing synthetic intermediates of 2-alkynyladenosines and (1995-10-17),

4. 5283327 - Tri-O-acetyl-2-alkynyladenosines (1994-02-01),

5. 5270304 - Therapeutic 2-alkynyl adenosine agent for ischemic diseases of the heart (1993-12-14),

6. 5149702 - Cycloheptenopyridine derivatives, process for preparation thereof and (1992-09-22),

7. 5117037 - Cis-bicyclo[4,3.0]non-2-end derivatives (1992-05-26),

8. 4874760 - 4,7-dihydroisothiazolo(5,4-b)pyridine derivatives and cardiovascular (1989-10-17),

9. 4837342 - Prostacyclin analogue, and blood circulation improving agent and (1989-06-06),

Title: The Innovative Mind of Kentaro Kogi

Introduction

Kentaro Kogi, an inventive researcher based in Fukushima, Japan, has made significant contributions to the field of medicinal chemistry through his innovative inventions. With a total of 9 patents to his name, Kogi has developed compounds that hold potential for treating various circulatory organ-related diseases, showcasing his commitment to advancing healthcare.

Latest Patents

Among Kentaro Kogi's latest patents are the following notable inventions:

1. **Cycloalkylpyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same** - This invention involves a cycloalkylpyridine-3-carbonylguanidine derivative that provides innovative solutions for drug formulation.

2. **Substituted cyclic amine compound and its production process** - Kogi has also developed a substituted cyclic amine compound characterized by a structural formula involving various substituents. The inventive compound exhibits significant utility in preventing and treating diseases such as hypertension, ischemic heart disease, cerebrovascular disease, and peripheral circulatory diseases.

Career Highlights

Kentaro Kogi has worked with reputable companies, including Toa Eiyo Ltd. and Yamasa Shoyu Kabushiki Kaisha. His experience in these organizations has allowed him to strengthen his expertise in the pharmaceutical and chemical industries, contributing to his innovative patent portfolio.

Collaborations

Throughout his career, Kogi has collaborated with distinguished coworkers, such as Shin-ichi Yamada and Toichi Abiru. These partnerships have fostered a conducive environment for creativity and innovation, ultimately leading to the development of his groundbreaking patents.

Conclusion

Kentaro Kogi remains a formidable figure in the realm of innovations and inventions, particularly in the medical field. His extensive work on patented compounds signifies his dedication to improving healthcare solutions. With each patent, he continues to impact lives positively, demonstrating the power of innovation in addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.